NeoPharm CO., LTD. (092730.KQ)
KRW 12780.0
(-4.91%)
KRW 12780.0
(-4.91%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 25.3 Billion KRW | 18.04% |
| 2022 | 21.43 Billion KRW | -4.42% |
| 2021 | 22.43 Billion KRW | 2.46% |
| 2020 | 21.89 Billion KRW | -4.65% |
| 2019 | 22.96 Billion KRW | 19.85% |
| 2018 | 19.15 Billion KRW | 36.3% |
| 2017 | 14.05 Billion KRW | 45.81% |
| 2016 | 9.63 Billion KRW | 54.19% |
| 2015 | 6.25 Billion KRW | 0.0% |
| 2014 | 5 Billion KRW | N/A |
| 2013 | 2.14 Billion KRW | N/A |
| 2012 | -121.87 Million KRW | 0.0% |
| 2011 | 1.19 Billion KRW | N/A |
| 2010 | 303.87 Million KRW | N/A |
| 2009 | 1.96 Billion KRW | N/A |
| 2008 | 3.49 Billion KRW | N/A |
| 2007 | 1.59 Billion KRW | N/A |
| 2006 | 3.42 Billion KRW | N/A |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 6.79 Billion KRW | -2.04% |
| 2024 Q3 | 5.08 Billion KRW | -16.76% |
| 2024 Q2 | 6.1 Billion KRW | -10.09% |
| 2023 Q1 | 7.03 Billion KRW | 17.11% |
| 2023 Q4 | 6.93 Billion KRW | 37.01% |
| 2023 FY | 25.3 Billion KRW | 18.04% |
| 2023 Q2 | 6.27 Billion KRW | -10.89% |
| 2023 Q3 | 5.06 Billion KRW | -19.33% |
| 2022 Q2 | 4.94 Billion KRW | -21.91% |
| 2022 Q4 | 6.01 Billion KRW | 45.18% |
| 2022 FY | 21.43 Billion KRW | -4.42% |
| 2022 Q3 | 4.14 Billion KRW | -16.35% |
| 2022 Q1 | 6.33 Billion KRW | 2.69% |
| 2021 Q4 | 6.17 Billion KRW | 78.81% |
| 2021 Q3 | 3.45 Billion KRW | -43.49% |
| 2021 FY | 22.43 Billion KRW | 2.46% |
| 2021 Q2 | 6.1 Billion KRW | -8.83% |
| 2021 Q1 | 6.69 Billion KRW | 2.07% |
| 2020 Q2 | 5.38 Billion KRW | -14.7% |
| 2020 FY | 21.89 Billion KRW | -4.65% |
| 2020 Q4 | 6.56 Billion KRW | 80.41% |
| 2020 Q1 | 6.31 Billion KRW | 12.41% |
| 2020 Q3 | 3.63 Billion KRW | -32.46% |
| 2019 FY | 22.96 Billion KRW | 19.85% |
| 2019 Q4 | 5.61 Billion KRW | 11.19% |
| 2019 Q1 | 6.33 Billion KRW | 10.21% |
| 2019 Q2 | 5.95 Billion KRW | -5.96% |
| 2019 Q3 | 5.05 Billion KRW | -15.19% |
| 2018 Q1 | 5.69 Billion KRW | 51.25% |
| 2018 FY | 19.15 Billion KRW | 36.3% |
| 2018 Q3 | 3.44 Billion KRW | -19.44% |
| 2018 Q2 | 4.27 Billion KRW | -24.88% |
| 2018 Q4 | 5.74 Billion KRW | 66.82% |
| 2017 Q1 | 4.27 Billion KRW | 148.14% |
| 2017 FY | 14.05 Billion KRW | 45.81% |
| 2017 Q2 | 3.5 Billion KRW | -18.13% |
| 2017 Q3 | 2.51 Billion KRW | -28.06% |
| 2017 Q4 | 3.76 Billion KRW | 49.42% |
| 2016 Q3 | 2.1 Billion KRW | -3.86% |
| 2016 FY | 9.63 Billion KRW | 54.19% |
| 2016 Q2 | 2.18 Billion KRW | -39.72% |
| 2016 Q4 | 1.72 Billion KRW | -18.07% |
| 2016 Q1 | 3.63 Billion KRW | 128.52% |
| 2015 Q2 | 1.09 Billion KRW | 0.0% |
| 2015 FY | 6.25 Billion KRW | 0.0% |
| 2015 Q3 | 1.13 Billion KRW | 3.29% |
| 2015 Q4 | 1.58 Billion KRW | 40.16% |
| 2013 Q2 | 233.11 Million KRW | -75.48% |
| 2013 Q1 | 950.56 Million KRW | 548.69% |
| 2013 Q3 | -646.38 Million KRW | -377.28% |
| 2012 Q4 | -211.85 Million KRW | 0.0% |
| 2012 FY | -121.87 Million KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Kolmar BNH Co., Ltd. | 30.25 Billion KRW | 16.356% |